Whitelist set to ease orphan drug imports in Beijing
3 months, 3 weeks ago

Whitelist set to ease orphan drug imports in Beijing

China Daily  

The Beijing government announced plans for a whitelist to expedite the import of orphan drugs approved overseas but not yet registered in China at a news conference Friday. The whitelist covers medical institutions, urgent orphan drugs and import companies, with the aim of reducing patient wait times. "It is a shift from patients waiting for drugs to drugs waiting for patients", said Cao Wei, head of the Beijing Municipal Medical Products Administration. Du Bin, deputy director of Peking Union Medical College Hospital, said: "We have already applied to the Beijing Municipal Medical Products Administration for more than 50 urgently needed orphan drugs."

Discover Related